Using Patient iPSC-derived Retinal Pigment Epithelial Cells to Evaluate Differential Susceptibility to MEK Inhibitor-Associated Retinopathy
Lola P. Lozano, Timothy M. Boyce, Andrew P. Groves, Henry L. Keen, H. Culver Boldt, Robert F. Mullins, Elaine M. Binkley, Budd A. Tucker
The paper compares MEK inhibitor effects on iPSC-derived RPE cells from patients with and without MEKAR, finding differential gene expression and phagocytic activity.
bioRxiv · Apr 14, 2026 · PreprintPharmacology & Toxicology